Key result
Non-alcoholic fatty liver disease was associated with a significantly higher frequency of obstructive coronary artery disease compared to normal liver tissue (27.9% vs 13.7%, p=0.002).
Why the study?
Is the presence of non-alcoholic fatty liver disease (NAFLD) associated with an increased prevalence of coronary artery disease in patients undergoing MSCT angiography?
Cross-Sectional (n=372)
No
Is the presence of non-alcoholic fatty liver disease (NAFLD) associated with an increased prevalence of coronary artery disease in patients undergoing MSCT angiography?
Absolute Event Rate: 27.9% vs 13.7%
p-value: p=0.002
NAFLD detected incidentally on MSCT is associated with a significantly higher prevalence of obstructive and non-obstructive coronary artery disease, suggesting it may serve as a marker for cardiovascular risk.
BACKGROUND: Some risk factors for atherosclerosis are followed by non-alcoholic fatty liver disease (NAFLD). We wanted to use Multislice computed tomography (MSCT) as technique for searching relationship between NAFLD and coronary artery disease (CAD). OBJECTIVE: The relationship between NAFLD and CAD was investigated using MSCT. METHODS: A total of 372 individuals with or without cardiac symptoms who had undergone MSCT angiography were included in the study. The patients were divided into two groups according to the presence of NAFLD. Coronary artery segments were visually evaluated via MSCT angiography. Based on the coronary artery stenosis degree, those with no or minimal plaques were considered normal, whereas those who had stenosis of less than 50% and at least one plaque were considered to have non-obstructive coronary artery disease (non-obsCAD). The patients who had at least one plaque and coronary artery stenosis of 50% or more were considered to have obstructive coronary artery disease (obsCAD). NAFLD was determined according to the MSCT protocol, using the liver density. RESULTS: According to the liver density, the number of patients with non-alcoholic fatty liver disease (group 1) was 204 (149 males, 54.8%) and with normal liver (group 2) was 168 (95 males, 45.2%). There were 50 (24.5%) non-obsCAD and 57 (27.9%) obsCAD cases in Group 1, and 39 (23.2%) non-obsCAD and 23 (13.7%) obsCAD cases in Group 2. CONCLUSIONS: The present study using MSCT demonstrated that the frequency of coronary artery disease in patients with NAFDL was significantly higher than that of patients without NAFDL.
No takes yet. Share an insight, caveat, or question.
Efe et al. (2013) conducted a cross-sectional in Non-alcoholic fatty liver disease and coronary artery disease (n=372). Non-alcoholic fatty liver disease vs. Normal liver was evaluated on Obstructive coronary artery disease (obsCAD) (p=0.002). Non-alcoholic fatty liver disease was associated with a significantly higher frequency of obstructive coronary artery disease compared to normal liver tissue (27.9% vs 13.7%, p=0.002).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: